A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study). [electronic resource]
Producer: 20150622Description: 663-9 p. digitalISSN:- 1532-3080
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- blood
- Biomarkers, Tumor -- metabolism
- Breast Neoplasms -- blood
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Humans
- Lapatinib
- Middle Aged
- Neoplasm Metastasis
- Quinazolines -- administration & dosage
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Tamoxifen -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.